Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
about
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
description
clinical trial
@en
klinisch onderzoek
@nl
name
Liposome-encapsulated Daunorub ...... treated Acute Myeloid Leukemia
@en
type
label
Liposome-encapsulated Daunorub ...... treated Acute Myeloid Leukemia
@en
prefLabel
Liposome-encapsulated Daunorub ...... treated Acute Myeloid Leukemia
@en
P4844
P1050
P1476
Phase II Study of CPX-351 in C ...... h Acute Myeloid Leukemia (AML)
@en
P3098
NCT03629171
P580
2018-10-29T00:00:00Z
P582
2020-06-30T00:00:00Z